Literature DB >> 7903631

Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide.

G Teitelman1, S Alpert, J M Polak, A Martinez, D Hanahan.   

Abstract

The early progenitor cells to the pancreatic islets in the mouse have been characterized so as to re-examine their possible lineage relationships to the four islet cell types found in mature islets. Insulin and glucagon were both first expressed at embryonic day 9.5, and many cells coexpressed these two markers, as shown by light and electron microscopic analysis using double-label immunohistochemistry. Incubation of embryonic pancreas with 1% glutaraldehyde, a fixative commonly used by electron microscopists, abolished this reactivity, thereby explaining reported difficulties in detecting these precursor cells. Using antisera specific for neuropeptide Y (NPY) a peptide with considerable homology to pancreatic polypeptide (PP), we show that NPY first appears with insulin and glucagon immunoreactivity at E9.5, and is co-expressed with glucagon in a majority of adult alpha cells. As we have previously reported, PP itself is first detectable immunocytochemically at postnatal day 1 with PP-specific antibodies. However, antibodies raised against bovine PP are shown by dot blotting to recognize NPY with comparable avidity, indicating that a recent report of islet progenitor cells containing PP at E9.5 (Herrera, P. L., Huarte, J., Sanvito, F., Meda, P., Orci, L. and Vassalli, J. D. (1991) Development 113, 1257-1265), actually represents cross-reactivity to NPY. The data support a model in which early precursor cells to the endocrine pancreas co-activate and co-express a set of islet cell hormone and neural genes, whose expression is both selectively increased and extinguished as development proceeds, concomitant with a restriction to the patterns of expression characteristic of mature islet cell types.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903631     DOI: 10.1242/dev.118.4.1031

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  97 in total

1.  Directed differentiation of embryonic stem cells allows exploration of novel transcription factor genes for pancreas development.

Authors:  Jing Sui; Munish Mehta; Bingyin Shi; Grant Morahan; Fang-Xu Jiang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Pancreatic beta cells require NeuroD to achieve and maintain functional maturity.

Authors:  Chunyan Gu; Gretchen H Stein; Ning Pan; Sandra Goebbels; Hanna Hörnberg; Klaus-Armin Nave; Pedro Herrera; Peter White; Klaus H Kaestner; Lori Sussel; Jacqueline E Lee
Journal:  Cell Metab       Date:  2010-04-07       Impact factor: 27.287

3.  Stage specific reprogramming of mouse embryo liver cells to a beta cell-like phenotype.

Authors:  Ying Yang; Ersin Akinci; James R Dutton; Anannya Banga; Jonathan M W Slack
Journal:  Mech Dev       Date:  2013-08-30       Impact factor: 1.882

4.  Nkx2.2-repressor activity is sufficient to specify alpha-cells and a small number of beta-cells in the pancreatic islet.

Authors:  Michelle J Doyle; Zoe L Loomis; Lori Sussel
Journal:  Development       Date:  2007-01-03       Impact factor: 6.868

5.  MafB is required for islet beta cell maturation.

Authors:  Isabella Artner; Bruno Blanchi; Jeffrey C Raum; Min Guo; Tomomi Kaneko; Sabine Cordes; Michael Sieweke; Roland Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-22       Impact factor: 11.205

Review 6.  Minireview: pancreatic progenitor cells--recent studies.

Authors:  Hsun Teresa Ku
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

7.  Neuropeptide Y expression marks partially differentiated β cells in mice and humans.

Authors:  Pope Rodnoi; Mohan Rajkumar; Abu Saleh Md Moin; Senta K Georgia; Alexandra E Butler; Sangeeta Dhawan
Journal:  JCI Insight       Date:  2017-06-15

8.  Stem cell therapy to treat diabetes mellitus.

Authors:  Chee Gee Liew; Peter W Andrews
Journal:  Rev Diabet Stud       Date:  2009-02-10

9.  N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.

Authors:  Zhi-Liang Chu; Chris Carroll; Ruoping Chen; Jean Alfonso; Veronica Gutierrez; Hongmei He; Annette Lucman; Charles Xing; Kristen Sebring; Jinyao Zhou; Brandee Wagner; David Unett; Robert M Jones; Dominic P Behan; James Leonard
Journal:  Mol Endocrinol       Date:  2009-11-09

10.  pdx-1 function is specifically required in embryonic beta cells to generate appropriate numbers of endocrine cell types and maintain glucose homeostasis.

Authors:  Maureen Gannon; Elizabeth Tweedie Ables; Laura Crawford; David Lowe; Martin F Offield; Mark A Magnuson; Christopher V E Wright
Journal:  Dev Biol       Date:  2007-11-04       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.